Related Articles
Carnosol inhibits osteoclastogenesis <em>in vivo</em> and <em>in vitro</em> by blocking the RANKL‑induced NF‑κB signaling pathway Retraction in /10.3892/mmr.2024.13369
Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritis
Receptor activator of NF-κB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro
Iguratimod prevents ovariectomy‑induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator‑activated receptor‑γ
Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways